Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
- PMID: 16013437
- DOI: 10.1007/s11010-005-5905-8
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Abstract
Use of the chemotherapeutic agent doxorubicin (Dox) is limited by dose-dependent cardiotoxic effects. The molecular mechanism underlying these toxicities are incompletely understood, but previous results have demonstrated that Dox induces p53 expression. Because p53 is an important regulator of the cell birth and death we hypothesized that targeted disruption of the p53 gene would attenuate Dox-induced cardiotoxicity. To test this, female 6-8 wk old C57BL wild-type (WT) or p53 knockout (p53 KO) mice were randomized to either saline or Dox 20 mg/kg via intraperitoneal injection. Animals were serially imaged with high-frequency (14 MHz) two-dimensional echocardiography. Measurements of left ventricle (LV) systolic function as assessed by fractional shortening (FS) demonstrated a decline in WT mice as early as 4 days after Dox injection and by 2 wk demonstrated a reduction of 31 +/- 16% (P < 0.05) from the baseline. In contrast, in p53 KO mice, LV FS was unchanged over the 2 wk period following Dox injection. Apoptosis of cardiac myocytes as measured by the TUNEL and ligase reactions were significantly increased at 24 h after Dox treatment in WT mice but not in p53 KO mice. After Dox injection, levels of myocardial glutathione and Cu/Zn superoxide dismutase were preserved in p53 KO mice, but not in WT animals. These observations suggest that p53 mediated signals are likely to play a significant role in Dox-induced cardiac toxicity and that they may modulate Dox-induced oxidative stress.
Similar articles
-
Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.J Mol Cell Cardiol. 2011 Sep;51(3):318-28. doi: 10.1016/j.yjmcc.2011.05.010. Epub 2011 May 23. J Mol Cell Cardiol. 2011. PMID: 21624372
-
Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.Toxicol Sci. 2016 May;151(1):44-56. doi: 10.1093/toxsci/kfw021. Epub 2016 Jan 27. Toxicol Sci. 2016. PMID: 26822305 Free PMC article.
-
Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.J Pharmacol Exp Ther. 2015 Nov;355(2):280-7. doi: 10.1124/jpet.115.225581. Epub 2015 Sep 9. J Pharmacol Exp Ther. 2015. PMID: 26354995 Free PMC article.
-
Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.Curr Hypertens Rep. 2009 Dec;11(6):389-95. doi: 10.1007/s11906-009-0068-8. Curr Hypertens Rep. 2009. PMID: 19895749 Free PMC article. Review.
-
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act.Nutrients. 2023 May 10;15(10):2259. doi: 10.3390/nu15102259. Nutrients. 2023. PMID: 37242146 Free PMC article. Review.
Cited by
-
The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients.Cancers (Basel). 2022 May 3;14(9):2288. doi: 10.3390/cancers14092288. Cancers (Basel). 2022. PMID: 35565417 Free PMC article. Review.
-
Acylated ghrelin prevents doxorubicin-induced cardiac intrinsic cell death and fibrosis in rats by restoring IL-6/JAK2/STAT3 signaling pathway and inhibition of STAT1.Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1151-1168. doi: 10.1007/s00210-019-01664-9. Epub 2019 May 16. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 31093684
-
Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice.Oxid Med Cell Longev. 2022 Jul 7;2022:2967142. doi: 10.1155/2022/2967142. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35847586 Free PMC article.
-
Nucleolar stress is an early response to myocardial damage involving nucleolar proteins nucleostemin and nucleophosmin.Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6145-50. doi: 10.1073/pnas.1017935108. Epub 2011 Mar 28. Proc Natl Acad Sci U S A. 2011. PMID: 21444791 Free PMC article.
-
High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte.Cells. 2023 Mar 31;12(7):1060. doi: 10.3390/cells12071060. Cells. 2023. PMID: 37048134 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous